Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis

Finding a way to preserve mitochondria: new pathogenic pathways in experimental multiple sclerosis

Bibliographic Details
Main Authors:	Andrea Mancini, Lorenzo Gaetani, Lucia Gentili, Massimiliano Di Filippo
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=1;spage=77;epage=78;aulast=Mancini

Similar Items

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
by: Lorenzo Gaetani, et al.
Published: (2021-01-01)

Synaptic Dysfunction in Multiple Sclerosis: A Red Thread from Inflammation to Network Disconnection
by: Laura Bellingacci, et al.
Published: (2021-09-01)

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis
by: Lorenzo Gaetani, et al.
Published: (2020-02-01)

The role of mitochondria in multiple sclerosis
by: Campbell, Graham Robert
Published: (2011)

Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis
by: Andrea Mancini, et al.
Published: (2018-05-01)

Editorial: Cognition in Multiple Sclerosis
by: Rosa Cortese, et al.
Published: (2021-08-01)

Cannabis and Multiple Sclerosis—The Way Forward
by: Thorsten Rudroff, et al.
Published: (2017-06-01)

Dimethyl fumarate as a treatment for multiple sclerosis : a role for mitochondria?
by: Schiza, Dimitra
Published: (2018)

The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters
by: Afshin Derakhshani, et al.
Published: (2021-08-01)

Potential pathogens in multiple sclerosis (MS
by: Mariola Zawada
Published: (2012-10-01)

Audiological Findings in Multiple Sclerosis (MS)
by: Elahe Shojaei Chagharvand
Published: (1996-09-01)

Identification of pathogenic autoantibody responses in multiple sclerosis
by: Elliott, Christina
Published: (2011)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
by: Federico Paolini Paoletti, et al.
Published: (2021-05-01)

MOTOR PATHWAY ABNORMALITY IN MULTIPLE SCLEROSIS
by: Orest Bolbocean, et al.
Published: (2009-09-01)

Pathway Approach to Decoding Multiple Sclerosis
by: Zuvich, Rebecca Lynn
Published: (2009)

Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis
by: Elena K. Fetisova, et al.
Published: (2019-01-01)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
by: Serena Brancati, et al.
Published: (2021-07-01)

Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis
by: Giovanni Manfredi, et al.
Published: (2016-06-01)

Neuregulin, an Effector on Mitochondria Metabolism That Preserves Insulin Sensitivity
by: Anna Gumà, et al.
Published: (2020-06-01)

The Agony of Choice? Preserved Affective Decision Making in Early Multiple Sclerosis
by: Nils C. Landmeyer, et al.
Published: (2020-09-01)

Clinical pathways for the care of multiple sclerosis patients
by: C. Oreja-Guevara, et al.
Published: (2010-04-01)

Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
by: Nicole Ziliotto, et al.
Published: (2019-04-01)

Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
by: Hans Lassmann
Published: (2019-01-01)

Functional Connectivity in Multiple Sclerosis: Recent Findings and Future Directions
by: Marlene Tahedl, et al.
Published: (2018-10-01)

Morphological Outer Retina Findings in Multiple Sclerosis Patients With or Without Optic Neuritis
by: Lucia Ziccardi, et al.
Published: (2020-09-01)

On the Correction of a Mental State in the Non-Drug Way at Multiple Sclerosis
by: Reznikova T.N., et al.
Published: (2019-07-01)

Is adversarial growth a helpful way of understanding adjustment to multiple sclerosis?
by: Ackroyd, Katie
Published: (2006)

Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis
by: Christine Konradi, et al.
Published: (2012-01-01)

Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis
by: Elena Obrador, et al.
Published: (2020-09-01)

Functional and structural changes in the visual pathway in multiple sclerosis
by: María Carcelén‐Gadea, et al.
Published: (2019-12-01)

Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
by: Chai K. Lim, et al.
Published: (2010-08-01)

Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression
by: Chai K. Lim, et al.
Published: (2010-01-01)

Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment
Published: (2015-03-01)

Finding their way

Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity
by: Michie Imamura, et al.
Published: (2020-12-01)

Pathogenic CD8 T cells in Multiple Sclerosis and its experimental models
by: Eric S. Huseby, et al.
Published: (2012-03-01)

Flavonoids and Mitochondria: Activation of Cytoprotective Pathways?
by: Anna Kicinska, et al.
Published: (2020-07-01)

A Mitochondria-Initiated Apoptotic Pathway
by: Xiaodong Wang
Published: (2001-01-01)

Clinical and neurophysiological findings in oligoclonal band negative multiple sclerosis patients
by: Mesaroš Šarlota, et al.
Published: (2003-01-01)

Quality of Life in Multiple Sclerosis: Are Depressive Findings as Effective as Physical Disability?
by: Mesrure Köseoğlu, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_n40ulgtl66f5t8eohakn144t31